First-in-Human Development Strategies

Download PDF Now!

Crucial and cost-effective factors to consider when transforming a pre-clinical development compound into a first-in-human, early-phase drug candidate. Drug developers must consider many factors when positioning a preclinical drug candidate to succeed in first-in-human clinical trials.

This executive summary will map out the preformulation studies needed to create the best development path for a drug candidate and describe oral and injectable clinical formulation options for short- and long-term success.

 

Latest content from Catalent

More content

Related resources

Supplier's Info Centre